Cargando…
Small-Molecule Bi-DOTA Complex for High-Performance CT and Spectral CT Bioimaging
OBJECTIVES: It is necessary to develop a high-performance and biocompatible contrast agent to accurately diagnose various diseases via in vivo computed tomography (CT) imaging. Here, we synthesized a small molecular Bi-DOTA complex as a high-performance contrast agent for in vitro and in vivo CT bio...
Autores principales: | Dai, Guidong, Zhang, Yu, Wang, Ximei, Wang, Xingyu, Jia, Juan, Jia, Fei, Yang, Lu, Yang, Chunmei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894608/ https://www.ncbi.nlm.nih.gov/pubmed/35251983 http://dx.doi.org/10.3389/fonc.2022.813955 |
Ejemplares similares
-
Achieving safe and high-performance gastrointestinal tract spectral CT imaging with small-molecule lanthanide complex
por: Che, Xiaoling, et al.
Publicado: (2023) -
Head-to-Head Comparison of (68)Ga-DOTA-TATE and (68)Ga-DOTA-JR11 PET/CT in Patients With Tumor-Induced Osteomalacia: A Prospective Study
por: Hou, Guozhu, et al.
Publicado: (2022) -
A systematic review of [(68)Ga]Ga-DOTA-FAPI-04 and [(18)F]FDG PET/CT in the diagnostic value of malignant tumor bone metastasis
por: Li, Lanying, et al.
Publicado: (2022) -
Small cell lung cancer mimicking lymphoma in CT and (68)Ga-DOTA-NOC PET/CT: A case report
por: Lu, Liyan, et al.
Publicado: (2018) -
Comparison of the Relative Diagnostic Performance of [(68)Ga]Ga-DOTA-FAPI-04 and [(18)F]FDG PET/CT for the Detection of Bone Metastasis in Patients With Different Cancers
por: Wu, Junhao, et al.
Publicado: (2021)